Design, development, and optimization of sumatriptan loaded ethosomal intra-nasal nanogel for brain targeting

Nagadivya Nerella; Bakshi  Vasudha

doi:10.69857/joapr.v12i4.610

Authors

Nagadivya Nerella School of Pharmacy, Anurag University, Venkatapur, Ghatkesar Rd, Hyderabad, Telangana 500088, India
Bakshi Vasudha School of Pharmacy, Anurag University, Venkatapur, Ghatkesar Rd, Hyderabad, Telangana 500088, India

DOI:

https://doi.org/10.69857/joapr.v12i4.610

Keywords:

Film hydration, vesicle size, zeta potential, intranasal delivery, ex vivo permeation, central composite design

Abstract

Background: Sumatriptan is one of the most essential drugs for treating migraine. However, dosage-related side effects are still a worry despite its 14 % oral bioavailability and recurrence of migraine-associated diseases. Methodology: The fundamental focus of the study is to develop the sumatriptan intra-nasal nano-ethsomal gel by film hydration technique with the aid of QbD principles that govern the varied compositions and blends of polymers like HPMC K100M and Phospolipon 90G to develop a sustained release dosage form. Results and discussion: The preliminary FT-IR and DSC studies revealed no interactions between the drug and their physical mixtures. The present study considered three observable responses: vesicle size, zeta potential, and percent drug release after 24 h, taken into consideration during the optimization of the ethosomal formulations utilizing 3² central composite designs (CCD). The vesicle size (122.23 nm), zeta potential (-40.2 mV), and drug release percentage (92.61 %) for all formulations were seen in the F12 batch after 24h. The p-XRD and SEM studies indicated that the nano-ethosomal gel was stable. The stability studies indicated the preparation of a more stable formulation for the parameters under the study protocol. Conclusion: Using a novel intra-nasal brain targeting approach by adapting the film hydration technique, the current issues might be addressed, and the drug's duration of residence at the absorption site uptake substantially increase. To efficiently modify the drug's residence through the intra-nasal route, this work focuses on developing a nano-ethosomal gel loaded with sumatriptan.

Downloads

Download data is not yet available.

References

Buse DC, Greisman JD, Baigi K, Lipton RB. Migraine progression: A systematic review. Headache, 59, 306–338 (2018)

Hannon J, Hoyer D. Molecular biology of 5-HT receptors. Behav Brain Res, 195, 198–213 (2008)

Peters GL. Migraine overview and summary of current and emerging treatment options. Am J Manag Care, 25, S23–S34 (2019)

Omar MM, Eleraky NE, El Sisi AM, Ali Hasan O. Development and evaluation of in-situ nasal gel formulations of nanosized transferosomal sumatriptan: Design, optimization, in vitro and in vivo evaluation. Drug Des Devel Ther, 13, 4413-4430 (2019)

Russo AF, Hay DL. CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond. Physiol Rev, 103,1565-1644 (2023)

Girotra P, Singh SK. Multivariate optimization of rizatriptan benzoate-loaded solid lipid nanoparticles for brain targeting and migraine management. AAPS PharmSciTech, 18, 517–528 (2017).

Frimpong-Manson K, Ortiz YT, McMahon LR, Wilkerson JL. Advances in understanding migraine pathophysiology: a bench to bedside review of research insights and therapeutics. Front Mol Neurosci, 17, 1355281 (2024).

Girotra P, Singh SK. A comparative study of orally delivered PBCA and APOE coupled BSA nanoparticles for brain targeting of sumatriptan succinate in therapeutic management of migraine. Pharm Res, 33, 1682–95 (2016)

Hansraj GP, Singh SK, Kumar P. Sumatriptan succinate loaded chitosan solid lipid nanoparticles for enhanced anti-migraine potential. Int J Biol Macromol, 81, 467-76 (2015)

Xu Y, Fourniols T, Labrak Y, Préat V, Beloqui A, des Rieux A. Surface Modification of Lipid-Based Nanoparticles. ACS Nano, 16, 7168-7196 (2022)

Ogundipe OD, Oladimeji FA. Water-in-Oil-in-Water multiple emulsions of ibuprofen for paediatrics using african walnut seed oil. J App Pharm Res, 7, 08-22 (2019)

Pourmand MR, Azar MS. Aghavalijamaat M. Development of validated UV spectrophotometric method for in vitro analysis of sumatriptan in pharmaceutical preparations in comparison with HPLC. Pharm Chem J, 44, 585–589 (2011)

Satyanarayana KV, Rao PN. Sensitive Bromatometric Methods for the Determination of Sumatriptan Succinate in Pharmaceutical Formulations. E J Chemistry, 8: 269-275, (2011)

Garg BJ, Garg NK, Beg S, Singh B, Katare OP. Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: formulation optimization, in vitro evaluation and preclinical assessment. J Drug Target, 24, 233-246 (2016)

Ghose D, Patra CN, Swain S, Sruti, J. Box-Behnken Design-based development and characterization of polymeric freeze-dried nanoparticles of isradipine for improved oral bioavailability. Int J App Pharm, 15, 60-70 (2023)

Chalmers, JM. Edwards HGM, Hargreaves MD. Infrared and raman spectroscopy in forensic science; Wiley, (2012)

Faroongsarng D. Theoretical aspects of differential scanning calorimetry as a tool for the studies of equilibrium thermodynamics in pharmaceutical solid phase transitions. AAPS PharmSciTech, 17, 572-7 (2016).

Swain S, Parhi R, Jena BR, Babu SM. Quality by Design: Concept to applications. Curr Drug Discov Technol, 16, 240-250 (2019)

Rukari T, Pingale PL, Upasani CD. Optimizing novasomes: impact of oleic acid and co-surfactant ratio on posaconazole delivery: In vitro & Ex vivo pharmacokinetic study. J App Pharm Res, 12, 88-98 (2024).

Sallustio V, Farruggia G, Di Cagno MP, et al. Design and characterization of an ethosomal gel encapsulating rosehip extract. Gels, 9, 362 (2023)

Zhang L, Mao S. Application of quality by design in the current drug development. Asian J Pharm Sci, 12, 1-8 (2017)

Mishra V, Thakur S, Patil A, Shukla A. Quality by design (QbD) approaches in current pharmaceutical set-up. Expert Opin Drug Deliv, 15, 737-758 (2018)

Simoes A, Veiga F, Vitorino C. Question-based review for pharmaceutical development: An enhanced quality approach. Eur J Pharm Biopharm, 195,114-174 (2024)

Pramod K, Tahir MA, Charoo NA, Ansari SH, Ali J. Pharmaceutical product development: A quality by design approach. Int J Pharm Investig, 6, 129-38 (2016)

Salem HF, El-Menshawe SF, Khallaf RA, Rabea YK. A novel transdermal nanoethosomal gel of lercanidipine HCl for treatment of hypertension: optimization using box-benkhen design, in vitro and in vivo characterization. Drug Deliv Transl Res, 10, 227-240 (2020)

Qureshi MI, Jamil QA, Usman F, Wani TA, Farooq M, Shah HS, Ahmad H, Khalil R, Sajjad M, Zargar S, Kausar S. Tioconazole-loaded transethosomal gel using box-behnken design for topical applications: In vitro, in vivo, and molecular docking approaches. Gels, 9, 767 (2019)

Iijima M, Hatakeyama T, Hatakeyama H. DSC and TMA studies of polysaccharide physical hydrogels. Anal Sci, 37, 211-219 (2021)

Smirnov I, Kaszkur Z, Hoell A. Development of nanoparticle bulk morphology analysis: a multidomain XRD approach. Nanoscale, 15, 8633-8642 (2023)

Apolinario AC, Salata GC, de Souza MM, Chorilli M, Lopes LB. Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a nanoethosomal-based hydrogel for topical administration of fenretinide. AAPS PharmSciTech, 23, 104 (2022)

Praveen A, Aqil M, Imam SS, Ahad A, Moolakkadath T, Ahmad FJ. Lamotrigine encapsulated intra-nasal nanoliposome formulation for epilepsy treatment: Formulation design, characterization and nasal toxicity study. Colloids Surf B Biointerfaces, 174, 553-562 (2019)

Zarrabi A, Alipoor Amro Abadi M, Khorasani S, Mohammadabadi MR, Jamshidi A, Torkaman S, Taghavi E, Mozafari MR, Rasti B. Nanoliposomes and tocosomes as multifunctional nanocarriers for the encapsulation of nutraceutical and dietary molecules. Molecules, 25, 638 (2020)

Bandyopadhyay S, Beg S, Katare OP, Sharma G, Singh B. QbD-Oriented development of self-nanoemulsifying drug delivery systems (SNEDDS) of valsartan with improved biopharmaceutical performance. Curr Drug Deliv, 12, 544-63 (2015)

Gonzalez-Gonzalez O, Ramirez IO, Ramirez BI, O'Connell P, Ballesteros MP, Torrado JJ, Serrano DR. Drug Stability: ICH versus accelerated predictive stability studies. Pharmaceutics, 14, 2324 (2022)

Shelke PV, Rachh PR, Mankar SD, Prasad LG. Optimization and evaluation of transdermal delivery system for nebivolol hydrochloride. J App Pharm Res, 12, 21-37 (2024).

Swain S, Beg S, Singh A, Patro ChN, Rao ME. Advanced techniques for penetration enhancement in transdermal drug delivery system. Curr Drug Deliv, 8, 456-73 (2011)

Phatale V, Vaiphei KK, Jha S, Patil D, Agrawal M, Alexander A. Overcoming skin barriers through advanced transdermal drug delivery approaches. J Control Release, 351, 361-380 (2022)